Suppr超能文献

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.

作者信息

Tan Darrell H S, Hull Mark W, Yoong Deborah, Tremblay Cécile, O'Byrne Patrick, Thomas Réjean, Kille Julie, Baril Jean-Guy, Cox Joseph, Giguere Pierre, Harris Marianne, Hughes Christine, MacPherson Paul, O'Donnell Shannon, Reimer Joss, Singh Ameeta, Barrett Lisa, Bogoch Isaac, Jollimore Jody, Lambert Gilles, Lebouche Bertrand, Metz Gila, Rogers Tim, Shafran Stephen

机构信息

Division of Infectious Diseases (Tan), St. Michael's Hospital, Toronto, Ont.; BC Centre for Excellence in HIV/AIDS (Hull, Harris), Vancouver, BC; Department of Pharmacy (Yoong), St. Michael's Hospital, Toronto, Ont.; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (Tremblay), Montréal, Que.; School of Nursing (O'Byrne), University of Ottawa, Ottawa, Ont.; Clinique L'Actuel (Thomas), Montréal, Que.; Canadian Association of Nurses in HIV/AIDS Care (Kille), Vancouver, BC; Clinique du Quartier Latin (Baril), Montréal, Que.; Direction régionale de santé publique (Cox), Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, Montréal, Que.; Department of Pharmacy (Giguere), The Ottawa Hospital, Ottawa, Ont.; Faculty of Pharmacy & Pharmaceutical Sciences (Hughes), University of Alberta, Edmonton, Alta.; Division of Infectious Diseases (MacPherson), The Ottawa Hospital, Ottawa, Ont.; Department of Emergency Medicine (O'Donnell), St. Paul's Hospital, Vancouver, BC; Winnipeg Regional Health Authority (Reimer), Winnipeg, Man.; Division of Infectious Diseases, Department of Medicine (Singh, Shafran), University of Alberta, Edmonton, Alta.; Dalhousie University (Barrett), Halifax, NS; Divisions of Internal Medicine and Infectious Diseases (Bogoch), Toronto General Hospital, Toronto, Ont.; Health Initiative for Men (Jollimore), Vancouver, BC; Institut national de santé publique du Québec (Lambert), Montréal, Que.; Research Institute of the McGill University Health Centre (Lebouche), Montréal, Que.; CATIE (Canadian AIDS Treatment Information Exchange) (Rogers), Toronto, Ont.

出版信息

CMAJ. 2017 Nov 27;189(47):E1448-E1458. doi: 10.1503/cmaj.170494.

DOI:10.1503/cmaj.170494
PMID:29180384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5703677/
Abstract
摘要

相似文献

1
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.
CMAJ. 2017 Nov 27;189(47):E1448-E1458. doi: 10.1503/cmaj.170494.
2
Prevention Strategies Against HIV Transmission: A Proactive Approach.
J Pharm Pract. 2018 Feb;31(1):82-90. doi: 10.1177/0897190017696946. Epub 2017 Mar 21.
3
Methods and Approaches to HIV Prevention.
J Assoc Nurses AIDS Care. 2017 Jan-Feb;28(1):19-24. doi: 10.1016/j.jana.2016.09.005. Epub 2016 Sep 22.
4
CDC Releases Updated Guidelines for Postexposure Prophylaxis After Sexual, Injection Drug, or Other Nonoccupational Exposures to HIV.
Am Fam Physician. 2016 Sep 1;94(5):392-3.
5
What Community-Based HIV Prevention Organizations Say About Their Role in Biomedical HIV Prevention.
AIDS Educ Prev. 2016 Oct;28(5):426-439. doi: 10.1521/aeap.2016.28.5.426.
6
Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV Exposures.
J Acquir Immune Defic Syndr. 2018 May 1;78(1):20-22. doi: 10.1097/QAI.0000000000001639.
7
Post-exposure prophylaxis in the era of pre-exposure prophylaxis: a study of post-exposure prophylaxis use in South-East Queensland since the Pharmaceutical Benefits Scheme listing of pre-exposure prophylaxis.
Int J STD AIDS. 2020 Apr;31(5):426-431. doi: 10.1177/0956462420911579. Epub 2020 Mar 19.
8
Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
Infect Dis Clin North Am. 2019 Sep;33(3):629-646. doi: 10.1016/j.idc.2019.04.002. Epub 2019 Jun 22.
9
The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
Clin Infect Dis. 2015 Jun 1;60 Suppl 3(Suppl 3):S200-4. doi: 10.1093/cid/civ094.
10
HIV Pre-Exposure Prophylaxis and Postexposure Prophylaxis in Japan: Context of Use and Directions for Future Research and Action.
AIDS Patient Care STDS. 2017 Feb;31(2):60-77. doi: 10.1089/apc.2016.0160.

引用本文的文献

1
Implementation and acceptance of pharmacists' prescribing of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP).
Can Pharm J (Ott). 2025 Aug 22:17151635251355277. doi: 10.1177/17151635251355277.
2
The Real-World Effectiveness of Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Adults in Alberta, Canada: A Retrospective Population-Based Cohort Study.
Can J Infect Dis Med Microbiol. 2025 Aug 10;2025:9340622. doi: 10.1155/cjid/9340622. eCollection 2025.
3
First case report of disseminated gonococcal arthritis in Newfoundland and Labrador.
Access Microbiol. 2025 Jan 30;7(1). doi: 10.1099/acmi.0.000807.v3. eCollection 2025.
4
Inequities in HIV prevention among trans and/or non-binary people: a cross-sectional survey analysis of PrEP and PEP awareness and use in Spain.
Int J Equity Health. 2025 Jul 7;24(1):197. doi: 10.1186/s12939-025-02574-4.
5
A Systematic Review of Guidelines for Emergency Department Care of Sexual Minorities: Implementable Actions to Improve Care.
West J Emerg Med. 2025 Mar 13;26(3):431-440. doi: 10.5811/westjem.20355.
6
Racial disparities in HIV pre-exposure prophylaxis (PrEP) awareness and uptake among white, Black, and Indigenous men in Canada: Analysis of data from the I'm Ready national HIV self-testing study.
Can J Public Health. 2025 Apr;116(2):243-253. doi: 10.17269/s41997-025-01009-5. Epub 2025 Mar 19.
7
Hepatitis C Virus Seroprevalence, Incidence, and Screening Patterns in Ontario Preexposure Prophylaxis Users.
Open Forum Infect Dis. 2025 Jan 15;12(1):ofaf014. doi: 10.1093/ofid/ofaf014. eCollection 2025 Jan.
8
The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021.
Can Commun Dis Rep. 2025 Jan 2;51(1):35-42. doi: 10.14745/ccdr.v51i01a05. eCollection 2025 Jan.
9
HIV risk assessment tools for identifying individuals who could benefit from pre-exposure prophylaxis: a systematic review protocol.
BMJ Open. 2024 Nov 7;14(11):e090565. doi: 10.1136/bmjopen-2024-090565.
10
Awareness and Uptake of HIV Preexposure Prophylaxis and Postexposure Prophylaxis Among College Students With Sexual Experiences: Institutional-Based Cross-Sectional Study.
JMIR Public Health Surveill. 2024 Nov 6;10:e63211. doi: 10.2196/63211.

本文引用的文献

1
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines.
J Virus Erad. 2017 Jul 1;3(3):168-184. doi: 10.1016/S2055-6640(20)30338-1.
2
A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis.
AIDS Behav. 2018 Apr;22(4):1063-1074. doi: 10.1007/s10461-017-1675-z.
3
Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
PLoS Med. 2016 Aug 23;13(8):e1002099. doi: 10.1371/journal.pmed.1002099. eCollection 2016 Aug.
4
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.
JAMA. 2016 Jul 12;316(2):191-210. doi: 10.1001/jama.2016.8900.
5
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
JAMA. 2016 Jul 12;316(2):171-81. doi: 10.1001/jama.2016.5148.
6
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis.
HIV Med. 2016 Jun;17(6):453-9. doi: 10.1111/hiv.12363. Epub 2016 May 11.
7
Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.
J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):287-94. doi: 10.1097/QAI.0000000000000858.
8
Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e115-8. doi: 10.1097/QAI.0000000000000906.
9
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1.
10
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验